Skip to contentBehbahani Ali — Bright Health Group Inc. insider: 266 transactions · InsiderLensBehbahani Ali
- 10% owner at Korro Bio, Inc. · on record since Nov 7, 2023
- 10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
- Director at Bright Health Group Inc. · on record since Oct 6, 2025
- Director at Arcellx, Inc. · on record since Apr 28, 2026
- Director at SCHERING PLOUGH CORP · on record since Feb 11, 2026
- 10% owner at SCHERING PLOUGH CORP · on record since Feb 11, 2026
- Director at CRISPR Therapeutics AG · on record since Jun 9, 2026
- Director at Nkarta, Inc. · on record since Jun 11, 2026
- Director at Korro Bio, Inc. · on record since Jun 11, 2026
- Director at Monte Rosa Therapeutics, Inc. · on record since Jun 12, 2026
- Director at NEVRO CORP · on record since Nov 7, 2014
- Director at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
- Director at GENOCEA BIOSCIENCES, INC. · on record since Feb 12, 2018
- 10% owner at Regulus Therapeutics Inc. · on record since Jul 17, 2018
- 10% owner at ACTELIS NETWORKS INC · on record since Jul 17, 2018
- 10% owner at GENOCEA BIOSCIENCES, INC. · on record since Jul 17, 2018
- Director at TAPIMMUNE INC · on record since Oct 18, 2018
- 10% owner at Trevi Therapeutics, Inc. · on record since May 13, 2019
- 10% owner at Mirum Pharmaceuticals, Inc. · on record since Jul 24, 2019
- Director at Oyster Point Pharma, Inc. · on record since Oct 30, 2019
- Director at Black Diamond Therapeutics, Inc. · on record since Jan 29, 2020
- 10% owner at Black Diamond Therapeutics, Inc. · on record since Jan 29, 2020
- 10% owner at Akouos, Inc. · on record since Jun 25, 2020
- 10% owner at Metacrine, Inc. · on record since Sep 22, 2020
- 10% owner at TAPIMMUNE INC · on record since Mar 18, 2021
- Former 10% Owner at Regulus Therapeutics Inc. · on record since Mar 16, 2021
- 10% owner at ADVENTRX PHARMACEUTICALS INC · on record since Mar 16, 2021
- 10% owner at Monte Rosa Therapeutics, Inc. · on record since Jun 30, 2021
- 10% owner at Bright Health Group Inc. · on record since Jun 30, 2021
- Director at Candev Resource Exploration, Inc. · on record since Jun 29, 2021
- Director at MINERVA SURGICAL INC · on record since Oct 28, 2021
Insider trading activity of Behbahani Ali
- Transactions on record
- 266
- since Nov 7, 2014
- Open-market buys
- 23
- $215.8M
- Open-market sells
- 12
- $1.5M
- Companies traded
- 22
- last filing Jun 29, 2026
Figures computed from official regulatory filings — methodology.
Companies where Behbahani Ali has traded
- Black Diamond Therapeutics, Inc.34 tx · $20.5M · Jun 29, 2026
- Monte Rosa Therapeutics, Inc.13 tx · $20M · Jun 12, 2026
- Nkarta, Inc.7 tx · Jun 11, 2026
- Korro Bio, Inc.8 tx · $6M · Jun 11, 2026
- CRISPR Therapeutics AG14 tx · Jun 9, 2026
- Arcellx, Inc.14 tx · Apr 28, 2026
- Trevi Therapeutics, Inc.15 tx · $40M · Feb 13, 2026
- SCHERING PLOUGH CORP14 tx · $15M · Feb 11, 2026
- Bright Health Group Inc.57 tx · $372.8M · Oct 6, 2025
Track record of Behbahani Ali
Statistical track record
Free- Open-market buys
- 46
- Last buy
- Feb 9, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Behbahani Ali
Co-insiders of Behbahani Ali
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
14 tx · $25.3M · Aug 19, 2025
MAKOWER JOSHUAADVENTRX PHARMACEUTICALS INC +11
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 29, 2026 | AwardD | 40,000 | 0.00 USD | — | SEC |
| Jun 22, 2026 | Award | 8,961 | 1.66 USD | — | SEC |
| Jun 12, 2026 | AwardD | 25,800 | 0.00 USD | $0 | SEC |
| Jun 11, 2026 | AwardD | 37,000 | 0.00 USD | $0 | SEC |
| Jun 11, 2026 | AwardD | 14,677 | 0.00 USD | $0 | SEC |
| Jun 9, 2026 | AwardD | 13,000 | 0.00 USD | $0 | SEC |
| Apr 28, 2026 | Other | -1,925 | — | — | SEC |
| Apr 28, 2026 | OtherD | -11,459 | — | — | SEC |
| Apr 28, 2026 | OtherD | -9,174 | — | — | SEC |
| Apr 28, 2026 | Other | -2,706 | — | — | SEC |
| Apr 28, 2026 | OtherD | -8,011 | — | — | SEC |
| Mar 20, 2026 | Award | 6,919 | 2.15 USD | $14.9K | SEC |
| Mar 12, 2026 | AwardD | 242,945 | 11.11 USD | $2.7M | SEC |
| Mar 12, 2026 | Award | 207,100 | 11.11 USD | $2.3M | SEC |
| Feb 13, 2026 | OtherD | -1,851,852 | 0.00 USD | $0 | SEC |
| Feb 13, 2026 | Other | 1,851,852 | 1.37 USD | $2.5M | SEC |
| Feb 11, 2026 | Other | 1,619,240 | — | — | SEC |
| Feb 11, 2026 | OtherD | -402,273 | — | — | SEC |
| Feb 11, 2026 | Other | 1,370,168 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,619,240 | — | — | SEC |
| Feb 11, 2026 | Other | 1,370,168 | — | — | SEC |
| Feb 11, 2026 | OtherD | -954,990 | — | — | SEC |
| Feb 11, 2026 | Other | 954,990 | — | — | SEC |
| Feb 11, 2026 | OtherD | -1,370,168 | — | — | SEC |
| Feb 11, 2026 | Other | 737,962 | — | — | SEC |